ATC Group: C03BA04 Chlorthalidone

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C03BA04 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C03 Diuretics
3 C03B Low-ceiling diuretics, excl. thiazides
4 C03BA Sulfonamides, plain
5 C03BA04 Chlorthalidone

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 25 mg

Active ingredients in C03BA04

Active Ingredient Description
Chlortalidone

Chlortalidone is a benzothiadiazine (thiazide)-related diuretic with a long duration of action.

Related product monographs

Title Information Source Document Type  
HYGROTON Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Australia (AU)

Austria (AT)

Ecuador (EC)

Germany (DE)

Mexico (MX)

New Zealand (NZ)

Poland (PL)

Romania (RO)

South Africa (ZA)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.